Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB01609_DB08895> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB01609_DB08895 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01609_DB08895 label "DDI between Deferasirox and Tofacitinib - Tofacitinib (and other CYP3A4 substrates), when used in combination with deferasirox, may experience a decrease in concentration. It is recommended to monitor therapy. [drugbank_resource:DB01609_DB08895]" assertion.
- drugbank_resource:DB01609_DB08895 identifier "drugbank_resource:DB01609_DB08895" assertion.
- drugbank_resource:DB01609_DB08895 title "DDI between Deferasirox and Tofacitinib - Tofacitinib (and other CYP3A4 substrates), when used in combination with deferasirox, may experience a decrease in concentration. It is recommended to monitor therapy." assertion.